Neuphoria Therapeutics NEUP Estimates

NASDAQ NEUP
$3.95 +0.02 (+0.51%)
At close: Aug 20, 2026 · 4:00 PM EDT

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Annual Revenue Estimates

Metric 202120222023202420252026202720282029
Reported (Actual) -183,700.00943,160.00958,610.0015.65 M-
High Estimate 6.78 M-676,756.47815,508.451.78 M11.57 M0.00
Low Estimate 6.15 M-735,463.89694,133.251.57 M10.58 M0.00
Consensus Estimate 6.46 M-706,110.18754,820.851.68 M11.08 M0.00

Annual Earnings Per Share (EPS) Estimates

Metric 202120222023202420252026202720282029
Reported (Actual) -15.69-30.10-29.64-21.62-0.23--
High Estimate -15.54-28.98-25.28-26.660.44-3.80-2.29
Low Estimate -17.70-32.26-29.80-32.360.36-4.10-2.79
Consensus Estimate -16.62-30.62-27.54-29.510.40-3.95-2.54